137 related articles for article (PubMed ID: 8047138)
1. Nm23-H1 mutation in neuroblastoma.
Chang CL; Zhu XX; Thoraval DH; Ungar D; Rawwas J; Hora N; Strahler JR; Hanash SM; Radany E
Nature; 1994 Aug; 370(6488):335-6. PubMed ID: 8047138
[No Abstract] [Full Text] [Related]
2. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.
Leone A; Seeger RC; Hong CM; Hu YY; Arboleda MJ; Brodeur GM; Stram D; Slamon DJ; Steeg PS
Oncogene; 1993 Apr; 8(4):855-65. PubMed ID: 8384356
[TBL] [Abstract][Full Text] [Related]
3. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
5. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene.
Chen HC; Wang L; Banerjee S
Oncogene; 1994 Oct; 9(10):2905-12. PubMed ID: 8084595
[TBL] [Abstract][Full Text] [Related]
7. DR-nm23 expression affects neuroblastoma cell differentiation, integrin expression, and adhesion characteristics.
Amendola R; Martinez R; Negroni A; Venturelli D; Tanno B; Calabretta B; Raschellà G
Med Pediatr Oncol; 2001 Jan; 36(1):93-6. PubMed ID: 11464913
[TBL] [Abstract][Full Text] [Related]
8. nm23--a metastasis suppressor gene?
Royds JA; Rees RC; Stephenson TJ
J Pathol; 1994 Jul; 173(3):211-2. PubMed ID: 7931840
[No Abstract] [Full Text] [Related]
9. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
[TBL] [Abstract][Full Text] [Related]
10. Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.
Valentijn LJ; Koster J; Versteeg R
Genomics; 2006 Apr; 87(4):483-9. PubMed ID: 16442775
[TBL] [Abstract][Full Text] [Related]
11. Independent and differential expression of two isotypes of human Nm23: analysis of the promoter regions of the nm23-H1 and H2 genes.
Okada K; Urano T; Baba H; Furukawa K; Furukawa K; Shiku H
Oncogene; 1996 Nov; 13(9):1937-43. PubMed ID: 8934540
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G
Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma.
Roymans D; Willems R; Vissenberg K; De Jonghe C; Grobben B; Claes P; Lascu I; Van Bockstaele D; Verbelen JP; Van Broeckhoven C; Slegers H
Exp Cell Res; 2000 Nov; 261(1):127-38. PubMed ID: 11082283
[TBL] [Abstract][Full Text] [Related]
14. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
Borchers H; Meyers FJ; Gumerlock PH; Stewart SL; deVere White RW
J Urol; 1996 Jun; 155(6):2080-4. PubMed ID: 8618340
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.
de la Rosa A; Mikhak B; Steeg PS
Arch Med Res; 1996; 27(3):395-401. PubMed ID: 8854401
[TBL] [Abstract][Full Text] [Related]
16. Genetic instability, p53 and nm23 mutation and clinicopathological features in rectal carcinoma.
Indinnimeo M; Cicchini C; Stazi A; Mingazzini P; Caligo MA; Ghimenti C; Bevilacqua G
Anticancer Res; 1998; 18(2A):989-93. PubMed ID: 9615752
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
[TBL] [Abstract][Full Text] [Related]
18. nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma.
Schneider J; Pollán M; Jiménez E; Marenbach K; Martínez N; Volm M; Marx D; Meden H
Br J Cancer; 2000 May; 82(10):1662-70. PubMed ID: 10817501
[TBL] [Abstract][Full Text] [Related]
19. Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.
Arai T; Watanabe M; Onodera M; Yamashita T; Masunaga A; Itoyama S; Itoh K; Sugawara I
Am J Pathol; 1993 Jun; 142(6):1938-44. PubMed ID: 8389529
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of NM23-1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuli.
Backer MV; Kamel N; Sandoval C; Jayabose S; Mendola CE; Backer JM
Anticancer Res; 2000; 20(3A):1743-9. PubMed ID: 10928103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
